BioVinc Research Featured as Cover Story in JBMR Plus
PASADENA, California — BioVinc, LLC announced today that its research manuscript, “Effects of Hydroxybisphosphonate-Conjugated Sitafloxacin on Fracture Healing and Skeletal Growth in Mice,” has been selected as the cover article in the February issue of JBMR Plus, a peer-reviewed journal of the American Society for Bone and Mineral Research. The study evaluates the biological effects of OsteoFloxacin, BioVinc’s lead drug candidate designed to […]
BioVinc Presentation in 2024 ASBMR Meeting
BioVinc scientists and collaborators will present data at the 2024 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR). The meeting will be held on September 27 – 30, 2024. One poster will be presented per the following schedule, and abstracts will be published in the Journal of Bone and Mineral Research: […]
BioVinc Presentation in 2024 ARI Orthopaedics Conference – Orthopaedic Infection
BioVinc scientists and collaborators presented data at the 2024 ARI Orthopaedics Conference – Orthopaedic Infection which will be held on June 24 – 26, 2024. Ren, Y.; Xue, T.; Lekkala, S.; Tay, A.; Wang H.; Ebetino, F.H.; Neighbors, J.; Sun, S.; Schwarz, E.M.; Xie, C. Osseointegration of Hydroxy Bisphosphonate-Conjugated Sitafloxacin (HBCS) during Skeletal Growth and […]
BioVinc Presentations in 2023 24th ICPC Meeting
BioVinc scientists and collaborators will present data at the 2023 24th International Conference on Phosphorus Chemistry (ICPC) which will be held on November 12 – 16, 2023. Sun, S.; Ebetino, F.H.; Cherian, P.; Hu, E.; Neighbors, J.; McKenna, C.E.; Xie, C.; Schwarz, E.M. New Era of Bisphosphonates: Design of Bone Targeted Therapeutics. 24th International Conference on […]
BioVinc Presentations in 2023 ASBMR Meeting
BioVinc scientists and collaborators will present data at the 2023 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR). The meeting will be held on October 13 – 16, 2023. One poster will be presented per the following schedule, and abstracts will be published in the Journal of Bone and Mineral Research: […]
BioVinc Secures Multi-Million Dollar SBIR Fast-Track Grant from NIH/NIAID to Advance Treatment for Infected Fractures
BioVinc is thrilled to announce it has been awarded a prestigious multi-million dollar SBIR Fast-Track Phase I/II grant from the National Institutes of Health (NIH/NIAID). This funding will accelerate our research and development of cutting-edge treatments targeting infected fractures, a critical unmet medical need. Patients suffering from open fractures face an alarmingly high risk of […]
BioVinc Presentation in 2023 ORS Meeting
BioVinc scientists and collaborators will present data at the ORS 2023 Annual Meeting. The meeting will be held on February 10-14, 2023. Ren, Y.; Weeks, J.; Xue, T.; Rainbolt, J.; de Bentley, K.L.; Shu, Y.; Galloway, C.A.; Liu, Y.; Cherian, P.; Neighbors, J.; Ebetino, F.H.; Moriarty, T.F.; Sun, S.; Schwarz, E.M.; Xie, C. Efficacy of […]
BioVinc Presentation in 2022 ASBMR Meeting
BioVinc scientists and collaborators will present data at the 2022 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR). The meeting will be held on September 9 – 12, 2022. One poster will be presented per the following schedule, and abstracts will be published in the Journal of Bone and Mineral Research: […]
BioVinc Presentation in SNMMI 2022 Annual Meeting
BioVinc scientists and collaborators will present data at the ORS 2022 Annual Meeting. The meeting will be held on June 11 – 14, 2022. Haratipour, P.; Valkenburgh, J.V.; Chen, Q.; Li, J.; Kashemirov, B.A.; Sun, S.; Ebetino, F.H.; McKenna, C. E.; Chen, K. Development of a novel 18F-labeled bisphosphonate probe for PET imaging. SNMMI 2022 […]
BioVinc Presentation in 2022 ORS Meeting
BioVinc scientists and collaborators will present data at the ORS 2022 Annual Meeting. The meeting will be held on February 4 – 8, 2022. Xie, C.; de Bentley, K.L.; Xue, T.; Ren, Y.; Saito, M.; Ebetino, F.H.; Sun, S.; Schwarz, E.M. Development of bisphosphonate-conjugated antibiotics to target Staphylococcus aureus biofilm within the osteocyte lacuno-canalicular network […]